The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Activity of gemcitabine-oxalipaltin (GemOx) plus prednisolone in patients with castration-resistant prostate cancer (CRPC) for whom docetaxel-based chemotherapy failed.
Jae-Lyun Lee
No relevant relationships to disclose
Yesul Kim
No relevant relationships to disclose
Jin-Hee Ahn
No relevant relationships to disclose
MeeKyung Choi
No relevant relationships to disclose
Seung-Woo Hong
No relevant relationships to disclose
In Gab Jeong
No relevant relationships to disclose
Cheryn Song
No relevant relationships to disclose
Bum-Sik Hong
No relevant relationships to disclose
Jun Hyuk Hong
No relevant relationships to disclose
Choung-Soo Kim
No relevant relationships to disclose
Hanjong Ahn
No relevant relationships to disclose